These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565 [TBL] [Abstract][Full Text] [Related]
28. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Vandenberghe LH; Wang L; Somanathan S; Zhi Y; Figueredo J; Calcedo R; Sanmiguel J; Desai RA; Chen CS; Johnston J; Grant RL; Gao G; Wilson JM Nat Med; 2006 Aug; 12(8):967-71. PubMed ID: 16845388 [TBL] [Abstract][Full Text] [Related]
29. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. Kern A; Schmidt K; Leder C; Müller OJ; Wobus CE; Bettinger K; Von der Lieth CW; King JA; Kleinschmidt JA J Virol; 2003 Oct; 77(20):11072-81. PubMed ID: 14512555 [TBL] [Abstract][Full Text] [Related]
30. Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy. Jayandharan GR; Aslanidi G; Martino AT; Jahn SC; Perrin GQ; Herzog RW; Srivastava A Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3743-8. PubMed ID: 21321191 [TBL] [Abstract][Full Text] [Related]
31. Attachment of adeno-associated virus type 3H to fibroblast growth factor receptor 1. Blackburn SD; Steadman RA; Johnson FB Arch Virol; 2006 Mar; 151(3):617-23. PubMed ID: 16195782 [TBL] [Abstract][Full Text] [Related]
32. Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells. Zhang L; Rossi A; Lange L; Meumann N; Koitzsch U; Christie K; Nesbit MA; Moore CBT; Hacker UT; Morgan M; Hoffmann D; Zengel J; Carette JE; Schambach A; Salvetti A; Odenthal M; Büning H Hum Gene Ther; 2019 Oct; 30(10):1284-1296. PubMed ID: 31407607 [TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of a bovine adeno-associated virus. Schmidt M; Katano H; Bossis I; Chiorini JA J Virol; 2004 Jun; 78(12):6509-16. PubMed ID: 15163744 [TBL] [Abstract][Full Text] [Related]
34. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634 [TBL] [Abstract][Full Text] [Related]
35. Binding sites for adeno-associated virus Rep proteins within the human genome. Wonderling RS; Owens RA J Virol; 1997 Mar; 71(3):2528-34. PubMed ID: 9032395 [TBL] [Abstract][Full Text] [Related]
36. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Luebke AE; Foster PK; Muller CD; Peel AL Hum Gene Ther; 2001 May; 12(7):773-81. PubMed ID: 11339894 [TBL] [Abstract][Full Text] [Related]
38. DNA-binding activity of adeno-associated virus Rep is required for inverted terminal repeat-dependent complex formation with herpes simplex virus ICP8. Alex M; Weger S; Mietzsch M; Slanina H; Cathomen T; Heilbronn R J Virol; 2012 Mar; 86(5):2859-63. PubMed ID: 22205745 [TBL] [Abstract][Full Text] [Related]
39. The role of the adeno-associated virus capsid in gene transfer. Van Vliet KM; Blouin V; Brument N; Agbandje-McKenna M; Snyder RO Methods Mol Biol; 2008; 437():51-91. PubMed ID: 18369962 [TBL] [Abstract][Full Text] [Related]